Calidi Biotherapeutics Inc. (CLDI)
NYSE · Healthcare
Calidi Biotherapeutics Inc. annual/quarterly shareholder equity history from 2022 to 2022. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Calidi Biotherapeutics Inc. shareholder equity for the quarter ending December 31, 2022 were -50.4M.
- Calidi Biotherapeutics Inc. shareholder equity for 2022 were -50.4M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Calidi Biotherapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2022 | $-50 |
| Calidi Biotherapeutics Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2022-12-31 | $-50 |
Calidi Biotherapeutics Inc. Shareholder Equity — FAQ
Calidi Biotherapeutics Inc. (CLDI) shareholder equity over the last 1 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CLDI's shareholder equity history?
The chart and table above show Calidi Biotherapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.